New study aims to crack the code of head and neck cancer in korean patients

NCT ID NCT07190573

Recruiting now Knowledge-focused Sponsor: Samsung Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

The HOPE study is a long-term research project at Samsung Medical Center that will follow about 350 head and neck cancer patients each year. Researchers will collect medical information, tumor tissue, and blood samples to understand how the disease progresses and why some patients respond better to treatment than others. The goal is to find biological markers that can guide more personalized and effective treatments in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could identify biomarkers that help doctors choose the most effective treatments for individual head and neck cancer patients.
What could go wrong: This is an observational study, not a treatment trial. It will not directly test a new therapy, and finding useful biomarkers is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck cancer Head and Neck Neoplasms squamous cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEAD AND NECK CANCER

Contacts and locations

Locations

Samsung Medical Center
RECRUITING

Seoul, Seoul, 06351, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.